Copyright Investor's Business Daily
When the S&P 500 is rallying to all-time highs, you have to wonder about the stocks getting left out. Turns out analysts see great promise in some of them. Analysts say nine "left out" S&P 500 stocks that are down 30% or more this year — like Moderna (MRNA) and Kenvue (KVUE) — should rally 30% or more in the next 12 months, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge. Investors are looking for their newest entry point in what's turning out to be a massive rally. "This bull market has been on quite a run," said Jeff Buchbinder, chief equity strategist for LPL Financial. "The S&P 500 is up 35% since its April 8, 2025, year-to-date low, and up over 92% since it began on October 12, 2022, excluding dividends." With stocks up so much, where do you find some that aren't extended? Analysts have some ideas (although always make sure you look at the proper buy point). Buying Medical Waste? Several health care stocks are finding themselves on the wrong side of populist beliefs on medicine. Analysts seem to think the negativity is temporary. Take Moderna, a maker of vaccines at a time when the FDA is backing away from some inoculations. Shares are down nearly 40% this year. The stock's RS Rating has crumbled to just 8. Earnings don't look great either: EPS is seen falling 4% this year. But analysts are still positive. They're calling for the stock to be priced at 40.30 in 12 months, or 59% upside. Kenvue is a similar story. The company makes Tylenol, which the administration has named as a possible culprit for health issues. The stock is down 32% this year. And the RS Rating is a rock-bottom 6. Even so, analysts think the company's EPS will rise 8% in 2026. They peg the stock at 20.37 in 12 months for a 40.4% gain. Some of the beat-up S&P 500 stocks may stay that way. But analysts, at least, think a few will find a way to join the S&P 500 rally. Promising 'Left Out' S&P 500 Stocks Analysts see a 30% gain or better for these stocks that have fallen 30% or more this year Company Ticker YTD change 12-month upside Sector Moderna MRNA -39.0% 59.0% Health Care Alexandria Real Estate Equities ARE -35.5% 52.6% Real Estate GoDaddy GDDY -33.7% 44.4% Information Technology Kenvue KVUE -32.0% 40.4% Consumer Staples Fiserv FI -38.6% 34.7% Financials The Trade Desk TTD -56.0% 34.6% Communication Services Align Technology ALGN -36.1% 31.5% Health Care Chipotle Mexican Grill CMG -33.2% 31.4% Consumer Discretionary Oneok OKE -31.2% 31.3% Energy Source: IBD, S&P Global Market Intelligence Follow Matt Krantz on X (Twitter) @mattkrantz YOU MAY ALSO LIKE: Oracle Stock Pops 25% Despite Earnings Miss. Its AI Cloud Backlog Is Surging. Want To Trade Options? Try Out These Strategies Monitor IBD's "Breaking Out Today" List For Companies Hitting New Buy Points IBD Digital: Unlock IBD's Premium Stock Lists, Tools And Analysis Today
